Gallbladder cancer is a common malignancy of the biliary tract. It is the fifth common malignancy of the gastrointestinal tract in United States [1] and third in Northern India [2] . Despite [3] [4] [5] .
Gallbladder cancer has several histopathological features. In the majority of cases, it is an adenocarcinoma (85-90%) which can be papillary, nodular, tubular or a combination with varying degrees of invasions. The histopathological grade and degree of metaplasia have prognostic significance, whereas other histopathological types are undifferentiated or anaplastic carcinoma (2-7%), pure squamous cell carcinoma (1-6%) and adenosquamous carcinoma (1-4%) [6, 7] . Rare types of gallbladder cancer include malignant melanomas, lymphomas, sarcomas and carcinoid tumors. Fahim [8] Descriptive epidemiology is used to investigate the occurrence of gallbladder cancer in different population groups. The incidence rate of gallbladder cancer can be derived only from population-based cancer registries. However, the number of such registries in the world has increased steadily over the last 50 years, but in comparison with the availability of data on mortality, the population so covered remains limited. Furthermore, the populations served by cancer registries often comprise only the inhabitants of a major city and do not represent the country as a whole.
AGE
In general, the incidence of gallbladder cancer rises with advancing age. The enhanced susceptibility to cancer may result from the impairment of gene and immune functions associated with later stages of the life span.
Paraskevopoulos [14] reported that gallbladder cancer incidence rate increases progressively with age, particularly after the fifth decade. Sipetic [15] analysed the epidemiological situation of chosen malignant tumors of digestive tract for the period [21] .
SEX HORMONES
The preponderance of gallstones in women [20] suggests that female sex hormones play a role in the pathogenesis of gallstones which are present in a majority of cases of gallbladder cancer [211. Chen and Huminer [22] [23] . Early tumors had a significantly lower expression of p29 than advanced tumors and metastases [24] . Furthermore, the relationship between combined oral contraceptive and primary gallbladder cancer was examined in 58 cases and 355 controls participating in an international hospital based case-control study. Use of combined oral contraceptive at any time was not associated with the risk of developing gallbladder cancer. There was also no evidence that the oral contraceptives caused risk of gallbladder cancer in women with or without a prior history of gallbladder disease. A history of gallbladder disease or gallstones was a strong risk factor for gallbladder cancer [25] . Epidemiological studies also show a strong association between gallbladder cancer, obesity and estrogen [26, 27] .
Recently Lichtman [25] [28, 29] . Kamel and co-workers [30] found that mutations in p53 and c-erbB-2 play a major role in [36] . The expression of cfos protein plays an important role in the development of gallbladder neoplasia with increased immunoreactivity in gallbladder cancer but not in chronic cholecystitis, biliary tract and ampullary neoplasms [37] . Oncogenic K-ras codon 12 mutation was detected in 59% (30 of 51) of gallbladder carcinomas, 73% (8 of 11) of gallbladder dysplasia and in gallstones. This is an important precancerous lesion of gallbladder carcinogenesis [38] . Sasatomi et al. [39] found an increased frequency of apoptosis with the progression of gallbladder carcinoma. Oncogenic alterations of bcl-2 and p53 may also play a role in tumorigenesis of gallbladder carcinoma, but these changes had no correlation with spontaneous apoptosis [39] .
CHOLELITHIASIS
A history of gallbladder disease or gallstones is a strong risk factor for gallbladder cancer. In ultrasound findings, 4 out of 5 cases of primary carcinoma of the gallbladder had associated gallstones [40] . Gallstones or a previous cholecystectomy for gallstones was reported in 44% of women and 23% of men in a postmortem examination of patients in the Canton of Thrgau between 1989-1991. Among the gallstones carriers, 8% of women and 2.5% of men had developed a gallbladder carcinoma [41] . An interracial study has been carried out with respect to gallstone size, growth and the relation between stone size and gallbladder cancer. The prevalence of gallstones differs markedly among 1676 females (169 White, 531 Black and 976 American Indians). One-third of all gallbladder cancers in subjects with calculi was associated with large stones [42] . Thus the stone size might be used to determine the risk of gallbladder cancer in patients with gallstones.
Gallbladder cancer is detected in about one percent of patients undergoing cholecystectomy for gallstones in some studies [1, 43, 44] .
Bllesta-Vicente and co-workers [45] Juvonen and Niemela [48] analysed ABO [52] . Kimura [55] . Segmental adenomyomatosis of gallbladder, chronic inflammatory bowel disease [56] and polyposis coli [57] However, the possibility for preventing mortality from this disease through early detection of genetic markers may be possible in the future. Recent advances in molecular biology will help in understanding the mechanisms responsible for development of biological heterogeneity in gallbladder cancer, the pathogenesis of invasion and metastasis, and ultimately improved management of the disease and perhaps its prevention.
